ReviewInfectious medicine2025
Mysterious Oropouche virus: Transmission, symptoms, and control.
Review in Infectious medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Fatal coinfection with Oropouche virus and influenza A(H1N1)pdm09: Case report and post-mortem findings.Infectious medicine · 2026Article
- An engineered anti-Oropouche virus human-murine chimeric immunoglobulin M is a viable substitute for positive human serum controls in diagnostic serology assays.PLoS neglected tropical diseases · 2026Article
- Oropouche Virus (OROV) Vaccine Development for Vulnerable Populations: Epidemiological Context, Challenges and Future Directions.Vaccines · 2026Review
- Preclinical Models of Oropouche Virus Infection and Disease.Pathogens (Basel, Switzerland) · 2025Review
- Anthropophagic Florida mosquito species are poor vectors of prototype and emerging strains of oropouche virus.PLoS neglected tropical diseases · 2025Article
- Structure-Based Identification of Natural Inhibitors Targeting the Gc Glycoprotein of Oropouche Virus: An In Silico Approach.International journal of molecular sciences · 2025Article
- Oropouche Virus: An Emerging Arboviral Threat and Its Implications for Europe.Life (Basel, Switzerland) · 2025Review
- Review
- Insights into Antiviral Candidates against Oropouche Virus: A Molecular Dynamics Study.ACS physical chemistry Au · 2025Article
- Oropouche Virus: The Silent Threat of a Re-emerging Arbovirus.Archives of Razi Institute · 2025Review
- Oropouche virus infects human trophoblasts and placenta explants.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Oropouche virus (OROV) is a new zoonotic arbovirus that mostly affects Brazil and nearby countries. Since its discovery in 1955, it has caused more than 500,000 infections, with symptoms ranging from fever and headache to serious neuroinvasive disorders such as meningitis and encephalitis. The virus spreads through urban and sylvatic cycles via vectors such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.